Canopy Drops as Consumer Pot Preferences Shift Amid Covid
(Bloomberg) -- Canopy Growth Corp. reported a negative gross margin for its most recent quarter, showing just how far the cannabis company has to go to reach profitability.
The hit comes as consumer preferences shift to higher-end products, including high-THC items and marijuana that comes from a single strain of plant, Chief Executive Officer David Klein said in a phone interview. The evolution in tastes is due in part to customers spending more time at dispensaries as Covid-19 lockdowns relax, he said.
“We've now focused our cultivation to be more premium and more agile so we don't have those issues going forward,” Klein said. A prior trend toward value-priced offerings has continued, but price competition in that space has become tougher, prompting Canopy to pivot to mid-priced and premium offerings.
The big hit this quarter came from writing down C$87 million ($69.8 million) worth of cannabis inventory after demand was less than expected in Canada, Canopy's biggest market. That resulted in gross margin of negative 54% for its fiscal second quarter, which ended Sept. 30, the company reported Friday.
The company recorded a loss of C$163 million in adjusted earnings before interest, taxes, depreciation and amortization. Analysts expected a loss of C$50.2 million, according to estimates compiled by Bloomberg.
Canada's marijuana market has been disrupted by delays in distributing Covid-19 vaccines, which has slowed the reopening of the economy. Now that consumers are back in stores, Klein said they've become more sophisticated in their preferences.
“As consumers experiment, rather than be more generic around sativa or indica types of plants, they want specifics strains with a lineage,” he said. The company is becoming more nimble so that it can quickly scale up its cultivation based on its vast genetic library and is also scouring the market for strains that might interest its consumers, and working with craft growers, Klein added.
Canopy also pushed out its goal to hit positive adjusted Ebitda, without giving an exact timeline. Klein said it's been taking longer than expected to get the company's CBD products onto U.S. store shelves.
On a positive note, the brands it does have in the U.S. are doing well: Canopy's Martha Stewart CBD line in the U.S. remains one of the fastest growing brands in the industry, the company said. The company also has several options on the U.S. market.
Read more about its latest deal to buy pot-gummy maker if the U.S. legalizes
The shares tumbled 8.8% at 10:44 a.m. in New York. The stock had declined 46% this year through Thursday.
©2021 Bloomberg L.P.
-
One El Nino, India Can Handle. Two Could Break The Granary
India's grain stocks can absorb one bad year, but a second El Nino could drain the buffer in two to three years, economists say.
-
India's Troika Of Good Luck | Joining The Dots
As Jensen Huang's exit drags Nvidia down, a cooling AI trade and resilient earnings have revived investor interest in India. A likely RBI rate hike looms.
-
Talking Points This Week: Leadership Shock At Nvidia, Earnings Strength, And The Fog Over Hormuz
The Anthropic IPO pricing and first trading day, Nvidia's upcoming earnings, and any fresh signals from Iran will set the tone for the following week.
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.